Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Clinical Oncohematology. Basic Research and Clinical Practice, [S. l.], v. 16, n. 2, p. 227–228, 2023. DOI: 10.21320/6nkr3a68. Disponível em: https://bloodjournal.ru/index.php/coh/article/view/29. Acesso em: 11 dec. 2025.